A randomized controlled trial evaluating outcome impact of cilostazol in patients with coronary artery disease and at a high risk of cardiovascular disease

1 September 2019 (12:40 - 13:30)
Organised by:
Congress Presentation Part of: Evolving developments in anti-platelet therapy Antiplatelet Drugs ESC Premium Access ESC Congress 2019